Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    15014181 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate
2 Completed
Has Results
Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
Condition: Breast Cancer
Intervention: Drug: Zometa
3 Completed Effect of Aromatase Inhibitors on Bones and Genes
Conditions: Breast Cancer;   Postmenopausal
Interventions: Procedure: Dual x-ray absorptiometry (DXA);   Procedure: Blood draw;   Behavioral: Questionnaire
4 Recruiting Overcoming Endocrine Resistance in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Lapatinib;   Drug: Aromatase Inhibitors;   Drug: Placebo Lapatinib

Study has passed its completion date and status has not been verified in more than two years.